Spagpo Nanomedical AB engages in the provision of research and development within nanomedicine. The firm focuses on the development of nanomaterials for tumor diagnostics and treatment of cancer. Its projects include SpagoPix and Tumorad. The company was founded IN 2007 and is headquartered in Lund, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company